Japanese drugmaker Eisai Co. Ltd. said on Monday it had submitted a marketing authorization application in Japan for its Alzheimer’s drug lecanemab, which was recently granted accelerated ...

Merck & Co. and Eisai reported mixed results from a late-stage study of the cancer drugs Keytruda and Lenvima in patients with certain types of gastroesophageal cancer. Merck and Eisai on Friday ...

E-2086 is under clinical development by Eisai and currently in Phase I for Narcolepsy. According to GlobalData, Phase I drugs for Narcolepsy have an 80% phase transition success rate (PTSR) indication ...

Lenvatinib mesylate is under clinical development by Eisai and currently in Phase II for Osteosarcoma. According to GlobalData, Phase II drugs for Osteosarcoma have a 13% phase transition success rate ...

The constraint has been a lack of good drugs to treat those patients. Eisai and Biogen, with Leqembi, and Eli Lilly, with Kisunla, have begun the process of establishing a drug arsenal for ...

Bhavish Aggarwal holds nearly a 9% stake in Ola Consumer, 36% in the now publicly listed Ola Electric, and around 90% in Ola Krutrim Ola founder Bhavish Aggarwal is planning to restructure his ...

Ahead of Ola Consumer IPO this year, founder Bhavish Aggarwal will overhaul the corporate and management structure of Ola group and realign various businesses across his three ventures. Bhavish ...

She was last seen in Kalki 2898 AD and has not announced any new projects since then. Well, recently her photo with acid survivor Laxmi Agarwal has surfaced and it is going viral. The image is from ...

Dru Agarwal and his Landmark Event Co. for $11 million acquired the three-story building on Pier 70 in a deal that closed Wednesday, he told the Business Journal. Agarwal plans to keep the pier's ...

He was 75. Dr. Mukesh Aggarwal took on the role of representing the interests of first-generation Indian-American and immigrant physicians and doctors in Brevard. He founded the Eye Clinic and ...